Devices

First a little explanation about the new unique product with its own delivery system. This is not only a medication but also a matchstick-sized osmotic mini pump that is the size of a match and is placed just beneath the skin to deliver a continuous and consistent flow of medication for a year.

A new weight loss device, AspireAssist, offers a novel approach to cutting calories: draining them from the stomach before they are fully digested. The AspireAssist® system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly.

Senseonics' Eversense™ 90-day implantable CGM approved in Europe.

Innovation and improvement in CGMS technology has risen dramatically over the last 2 years, paving the way for the artificial pancreas.

According to Jenise Wong, MD, PhD, of the University of California San Francisco, who reported the results at an oral session at the joint meeting of the Endocrine Society and the International Congress on Endocrinology, “We need to really equip patients with better tools and education on how to use their data.” David Kliff responds: Now some would argue that this is why IDM is needed, as it not only collects and transmits data, but it provides for an easy interaction between the patient and their healthcare team; that it’s the healthcare team that’s doing all the data analytics; that all the patient needs to do is collect the data; and that this focus on data can actually make a patient tune out even when they are getting good advice. Here is a perfect example of what we are talking about. Read more

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. In this final installment, Dr. Hirsch summarizes his ADA 2015 presentation, including a comparison of the BD infusion set to the current popular model, and images showing the fluid within infusion sets as captured by MRI and ultrasound.

In a follow-up visit for an insulin-requiring patient with type 2 DM, it was obvious that the management of his DM had deteriorated. According to his girlfriend, this patient ate only 1-2 meals a day, but they tended to be high-carbohydrate meals. We reviewed the patient's insulin regimem in detail and ascertained that he was using the sliding scale correctly.

Convenient smartphone access to diabetes information.

Life Sciences division connecting with medical device and drug companies to improve diabetes care...

Unilife Corporation has launched the world’s first instant insulin patch, Imperium. Imperium is a prefilled, preassembled, multi-day wearable insulin pump for continuous subcutaneous insulin infusion and on-demand bolus delivery through the push of a button. It is equipped with Bluetooth connectivity to wirelessly connect with smartphone apps for patient reminders …